Catalyst Pharmaceutical Partners Files Investigational New Drug Application For CPP-109 To Treat Cocaine Addiction
10/19/2005 5:12:25 PM
More...
|
Catalyst Pharma Group, Inc. Release: Novel Agent For Intermittent Claudication, NM-702, Shows Clinical Benefit Trends In Phase II Clinical Study
10/19/2005 5:10:32 PM
More...
|
Catalyst CRO Joins Spacelabs Medical In Strategic Partnership
10/19/2005 5:08:46 PM
More...
|